UBS AM’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-20,800
| Closed | -$126K | – | 2822 |
|
|
2018
Q1 | $126K | Buy |
20,800
+4,400
| +27% | +$26.6K | ﹤0.01% | 2444 |
|
|
2017
Q4 | $158K | Hold |
16,400
| – | – | ﹤0.01% | 2357 |
|
|
2017
Q3 | $146K | Hold |
16,400
| – | – | ﹤0.01% | 2322 |
|
|
2017
Q2 | $207K | Hold |
16,400
| – | – | ﹤0.01% | 2205 |
|
|
2017
Q1 | $172K | Buy |
+16,400
| New | +$172K | ﹤0.01% | 2228 |
|
|
2016
Q4 | – | Sell |
-17,800
| Closed | -$210K | – | 2770 |
|
|
2016
Q3 | $210K | Hold |
17,800
| – | – | ﹤0.01% | 2442 |
|
|
2016
Q2 | $230K | Hold |
17,800
| – | – | ﹤0.01% | 2365 |
|
|
2016
Q1 | $285K | Sell |
17,800
-1,500
| -8% | -$24K | ﹤0.01% | 2242 |
|
|
2015
Q4 | $553K | Buy |
19,300
+1,800
| +10% | +$51.6K | ﹤0.01% | 2000 |
|
|
2015
Q3 | $498K | Sell |
17,500
-3,700
| -17% | -$105K | ﹤0.01% | 2020 |
|
|
2015
Q2 | $762K | Buy |
21,200
+1,100
| +5% | +$39.5K | ﹤0.01% | 1817 |
|
|
2015
Q1 | $584K | Buy |
20,100
+400
| +2% | +$11.6K | ﹤0.01% | 1901 |
|
|
2014
Q4 | $415K | Buy |
19,700
+1,800
| +10% | +$37.9K | ﹤0.01% | 2044 |
|
|
2014
Q3 | $347K | Hold |
17,900
| – | – | ﹤0.01% | 2060 |
|
|
2014
Q2 | $280K | Buy |
+17,900
| New | +$280K | ﹤0.01% | 2225 |
|